Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
January 31, 2020
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
Ana Alcaraz-Sanabria, Mariona Baliu-Piqué, Cristina Saiz-Ladera, et al.
Plos One
|
April 17, 2019
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, et al.
Theranostics
|
June 6, 2022
TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
Taewoo Kim, Jessica Johnston, Sonia Castillo-Lluva, et al.
Oncotarget
|
October 9, 2015
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses
Alberto Ocana, Josee-Lyne Ethier, Laura Díez-González, et al.
Oncotarget
|
October 27, 2017
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
Alberto Ocana, Marta Gil-Martin, Miguel Martín, et al.
Oncoimmunology
|
October 25, 2019
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
María Del Mar Noblejas-López, Cristina Nieto-Jiménez, Sara Morcillo García, et al.
Frontiers in Immunology
|
January 11, 2020
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
Javier Pérez-Pena, Janos Tibor Fekete, Raquel Páez, et al.
British Journal of Pharmacology
|
May 5, 2025
Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma
Szonja Anna Kovács, Tamás Kovács, András Lánczky, et al.
European Urology Oncology
|
July 7, 2019
Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Iván A Rodríguez-Fernández, Laura Rodríguez-Romo, David Hernandez-Barajas, et al.
Clinical Epigenetics
|
July 9, 2026
Tumor-type specific methylation patterns of MTAP in human samples and cell lines
Luis Álvarez-Carrión, Dalma Müller, Manuel Pedregal, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
January 31, 2020
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
Ana Alcaraz-Sanabria, Mariona Baliu-Piqué, Cristina Saiz-Ladera, et al.
Plos One
|
April 17, 2019
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, et al.
Theranostics
|
June 6, 2022
TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
Taewoo Kim, Jessica Johnston, Sonia Castillo-Lluva, et al.
Oncotarget
|
October 9, 2015
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses
Alberto Ocana, Josee-Lyne Ethier, Laura Díez-González, et al.
Oncotarget
|
October 27, 2017
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
Alberto Ocana, Marta Gil-Martin, Miguel Martín, et al.
Oncoimmunology
|
October 25, 2019
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
María Del Mar Noblejas-López, Cristina Nieto-Jiménez, Sara Morcillo García, et al.
Frontiers in Immunology
|
January 11, 2020
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
Javier Pérez-Pena, Janos Tibor Fekete, Raquel Páez, et al.
British Journal of Pharmacology
|
May 5, 2025
Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma
Szonja Anna Kovács, Tamás Kovács, András Lánczky, et al.
European Urology Oncology
|
July 7, 2019
Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Iván A Rodríguez-Fernández, Laura Rodríguez-Romo, David Hernandez-Barajas, et al.
Clinical Epigenetics
|
July 9, 2026
Tumor-type specific methylation patterns of MTAP in human samples and cell lines
Luis Álvarez-Carrión, Dalma Müller, Manuel Pedregal, et al.
Page
of 10